Clearside Biomedical Inc

8-K Bankruptcy or receivership; Other events Dec 29, 2025 8-K Delisting notice or listing-rule failure Dec 8, 2025 8-K Bankruptcy or receivership; Delisting notice or listing-rule failure; Regulation FD disclosure Nov 25, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Other events Oct 7, 2025 8-K Amended charter or bylaws Sep 11, 2025 8-K Amended charter or bylaws Sep 11, 2025 8-K Entered a material agreement Sep 8, 2025 8-K Delisting notice or listing-rule failure; Shareholder vote results Sep 3, 2025 8-K Delisting notice or listing-rule failure; Director or officer change Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Exit or disposal costs; Director or officer change; Other events Jul 17, 2025 8-K Amended charter or bylaws; Shareholder vote results May 30, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 27, 2025 8-K Delisting notice or listing-rule failure Feb 13, 2025 8-K Regulation FD disclosure; Other events Dec 12, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Regulation FD disclosure; Other events Oct 9, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Regulation FD disclosure Jul 24, 2024 8-K Shareholder vote results Jun 20, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Director or officer change; Regulation FD disclosure Apr 16, 2024 10-K Fiscal year ended 2023-12-31 Mar 12, 2024 8-K Results of operations (earnings release) Mar 12, 2024 8-K Entered a material agreement; Regulation FD disclosure Feb 8, 2024 8-K Entered a material agreement Feb 1, 2024 8-K Entered a material agreement Dec 28, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Results of operations (earnings release) Nov 13, 2023 8-K Entered a material agreement Nov 3, 2023 8-K Delisting notice or listing-rule failure Sep 29, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Results of operations (earnings release) Aug 14, 2023